Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

Search for biochem pharma in registrations and monthly communication reports

Refine monthly communication reports results by

Type
Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (13)
Results: 1-13 | Export
  1. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: FRANCESCO BELLINI, CHEF DE LA DIRECTION
    Registration: 2 of 2 (2001-02-28 to 2002-03-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  2. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: JACQUES LAPOINTE, PRESIDENT ET CHEF D'EXPLOITATION
    Registration: 2 of 2 (2001-02-28 to 2002-03-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  3. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: MICHEL CHOUINARD, VICE-PRESIDENT, OPERATION COMMERCIALES
    Registration: 2 of 2 (2001-02-28 to 2002-03-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  4. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: ROBERT DUGRÉ, VICE-PRÉSIDENT DÉVELOPPEMENT CORPORATIF, VACCINS
    Registration: 1 of 1 (2001-02-26 to 2002-03-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  5. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: ANDY SHELDON, DIRECTEUR SENIOR DES OPÉ`RATIONS COMMERCIALES
    Registration: 1 of 1 (2001-02-26 to 2002-03-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  6. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: RANDAL CHASE, VICE-PRESIDENT, SENIOR OPERATIONS, VACCINS
    Registration: 1 of 1 (2001-02-26 to 2002-03-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  7. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: GUY LORD, AVOCAT
    Registration: 3 of 3 (2001-02-20 to 2002-03-01)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  8. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: JACQUES LAPOINTE, PRESIDENT ET CHEF D'EXPLOITATION
    Registration: 1 of 2 (2000-02-21 to 2001-02-28)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  9. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: FRANCESCO BELLINI, CHEF DE LA DIRECTION
    Registration: 1 of 2 (2000-02-21 to 2001-02-28)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  10. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: MICHEL CHOUINARD, VICE-PRESIDENT, OPERATION COMMERCIALES
    Registration: 1 of 2 (2000-02-21 to 2001-02-28)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  11. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: GUY LORD, AVOCAT
    Registration: 2 of 3 (2000-02-21 to 2001-02-08)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  12. BIOCHEM PHARMA
    Type: In-house Corporation
    Responsible officer: GUY LORD, AVOCAT
    Registration: 1 of 3 (1999-08-12 to 2000-02-21)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  13. BIOCHEM VACCINS
    Type: Consultant
    Lobbyist: GHISLAIN DUFOUR, CABINET DE RELATIONS PUBLIQUES NATIONAL INC. (LE)
    Registration: 1 of 1 (1998-08-11 to 2005-06-10)
    Submitted prior to the Lobbying Act coming into force on July 2, 2008.
    Subject matter details: 1
    Government institutions: 3
    Communication techniques: 2
    Government funding: No

Date Modified: